|Mr. Dwight H. Egan||Chairman, CEO & Pres||295k||N/A||1953|
|Dr. Brent C. Satterfield||Co-Founder & Chief Science Officer||237.5k||N/A||1977|
|Mr. Reed L. Benson||CFO & Sec.||215k||N/A||1948|
|Dr. Mayuranki Almaula||Sr. VP of Overseas Operations & Strategic Alliances||N/A||N/A||N/A|
|Mr. Cameron Gundry||Head of Commercialization LATAM/EUR||N/A||N/A||N/A|
Co-Diagnostics, Inc., a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules. It also intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was founded in 2013 and is headquartered in Salt Lake City, Utah.
Co-Diagnostics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.